MOTS-c, TRIM72 and Plasma-Membrane Repair
A multi-model study examined whether MOTS-c participates in membrane repair through interactions with TRIM72 and membrane lipids.
Study design
The researchers combined exercise-associated human observations with cell injury assays, protein-interaction studies, TRIM72-deficient mice and an ischaemia-reperfusion model.
What the researchers reported
The paper reported interactions between MOTS-c and TRIM72, enhanced trafficking of TRIM72 toward injured membrane, and membrane-related effects that were reduced when TRIM72 was absent. Additional interaction with a membrane phospholipid was reported.
What this result does not establish
The human component was correlational and the causal tests were preclinical. These findings do not establish a membrane-repair therapy or human clinical effect.
This article summarizes one published study about MOTS-c. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.
Related research material
Review the corresponding catalogue listing, labelled amount and available documentation. The study may use a different formulation or experimental preparation; it does not verify our product, its batch or suitability for human use.
Our Approach
Evidence before assumption.
TAM Global Research focuses on transparent documentation, careful scientific interpretation and clear distinction between what available evidence supports and what requires further verification.
Explore our quality standards